Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s):  QNTM

Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.


CSE:QNTM - Post by User

Bullboard Posts
Comment by Defaulteron Sep 01, 2018 3:54pm
90 Views
Post# 28553169

RE:RE:Question for the board

RE:RE:Question for the boardThis is all I needed to know.

Defaulter wrote:

CSE: HUGE
OTC: FSDDF
FRA: 0K9

TORONTO, Aug. 30, 2018 /PRNewswire/ -  FSD Pharma Inc. ("FSD Pharma" or the "Company") (CSE: HUGE) (OTC: FSDDF) reported its financial and operational results for the second quarter of fiscal 2018, ended June 30th, 2018.   These filings are available for review on the Company's SEDAR profile at www.sedar.com.

Highlights of The Company:

  • Completion of 25,000 square feet solely owned by FSD Pharma
  • Construction underway of the Auxly partnership Phase 1  approx. 220,000 Sq Ft expansion at Cobourg, Ontario, with a total budget of $55,000,000
  • Construction of Phase 1, approx. 105,000 Sq FT by Cannara partnership at the facility close to Montreal, Quebec underway
  • The first cannabis crop has been harvested and tested which is an essential step in the granting of a sales license
  • Strong Cash position at June 30, 2018 with $31.7 Million Cash and even more in liquid assets
  • No Debt

 

The construction in Coburg, Ontario remains on schedule with cultivation expected to commence in the first half of 2019. The Company maintained a strong balance sheet with cash of $31,700,000, no debt, significant assets and continues to execute on management's vision of becoming the largest indoor grow facility in the world with total grow capacity, once completed, in excess of 3,000,000 square feet. With an expected annual output of 400,000,000 grams of which FSD Pharma would benefit 200,000,000 grams.



BlueSkiesAhead wrote: I’m new to the board here but have had my eye on HUGE for a while. Currently HUGE has 25K square feet of cultivation space but the additional 220,000 square feet is supposed to be operational by the end of this year. Has it been stated what they believe their annual yield in KGs is once this space is operational by years end?

thanks in advance and GLTA

Cheers,

BSA




Bullboard Posts